Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Review

Published on 05 Dec 2024

Advances in DLL3-targeted therapies for small cell lung cancer: challenges, opportunities, and future directions

in Cancer Molecular Targets and Therapeutics

Jianhua Ding
Chaihong Yeong

Frontiers in Oncology

doi 10.3389/fonc.2024.1504139

5,233 views
3 citations

Review

Published on 04 Dec 2024

Targeting the SMURF2-HIF1α axis: a new frontier in cancer therapy

in Cancer Molecular Targets and Therapeutics

Emile Youssef
Shuai Zhao
Connor Purcell
Gary L. Olson
Wafik S. El-Deiry

Frontiers in Oncology

doi 10.3389/fonc.2024.1484515

3,649 views
4 citations

Review

Published on 03 Dec 2024

The role of N6-methyladenosine modification in tumor angiogenesis

in Cancer Molecular Targets and Therapeutics

Lifei Qin
Xinya Zeng
Xinze Qiu
Xingmei Chen
Shiquan Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1467850

1,550 views

Original Research

Published on 02 Dec 2024

Metabolomics and network pharmacology–guided analysis of TNF-α expression by Argemone mexicana (Linn) targeting NF-kB the signalling pathway in cancer cell lines

in Cancer Molecular Targets and Therapeutics

Sunanda Kulshrestha
Anjana Goel
Subhadip Banerjee
Rohit Sharma
Mohammad Rashid Khan
Kow-Tong Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1502819

2,158 views
2 citations

Review

Published on 29 Nov 2024

Crosstalk between lactate and tumor-associated immune cells: clinical relevance and insight

in Cancer Molecular Targets and Therapeutics

Kemin Sun
Ye Shen
Xiang Xiao
Hao Xu
Quanli Zhang
Ming Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1506849

1,762 views
3 citations

Systematic Review

Published on 29 Nov 2024

Circular RNA CDR1as/ciRS-7– a novel biomarker in solid tumors

in Cancer Molecular Targets and Therapeutics

Yun Zhang
Chanyu Xiong
Zhilin Jiang
Xiao Wang
Juanjuan Ji
Yan Pan
Tianshu Yu
Zihao Wang
Lin Zhu
Yumei Yue

Frontiers in Oncology

doi 10.3389/fonc.2024.1468363

1,381 views

Original Research

Published on 29 Nov 2024

The role of ATP6V0D2 in breast cancer: associations with prognosis, immune characteristics, and TNBC progression

in Cancer Molecular Targets and Therapeutics

Jingyu Zhang
Lixian Yang
Bin Xu
Haibo Ji
Shuo Liu
Xiaohan Wang
Xiaolong Li
Quanle Wang
Zhenchuan Song

Frontiers in Oncology

doi 10.3389/fonc.2024.1511810

1,601 views
1 citation

Original Research

Published on 27 Nov 2024

EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancer

in Cancer Molecular Targets and Therapeutics

Huilin Cui
Qianqian Yu
Qumiao Xu
Chen Lin
Long Zhang
Wei Ye
Yifei Yang
Sijia Tian
Yilu Zhou
Runzhe Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1433033

2,727 views
1 citation

Original Research

Published on 27 Nov 2024

Estrogenized HSA induced high-affinity autoantibodies in breast cancer - Novel biomarker for early detection

in Cancer Molecular Targets and Therapeutics

Subuhi Sherwani
Mohd Wajid Ali Khan
Wahid Ali Khan
Saravanan Rajendrasozhan
Khalid Al-Motair
Hamda Khan
Saheem Ahmad

Frontiers in Oncology

doi 10.3389/fonc.2024.1493320

910 views

Brief Research Report

Published on 26 Nov 2024

Targeted transcriptomic analysis of well-differentiated and dedifferentiated liposarcoma reveals multiple dysregulated pathways including glucose metabolism, TGF-β, and HIF-1 signaling

in Cancer Molecular Targets and Therapeutics

Ashley Patton
Natalie Horn
Puja Upadhaya
Patricia Sarchet
Raphael E. Pollock
Steve Oghumu
Obiajulu Hans Iwenofu

Frontiers in Oncology

doi 10.3389/fonc.2024.1456071

1,388 views

Original Research

Published on 26 Nov 2024

Comprehensive prognostic gene identification and functional characterization of GRAMD1A in Wilms tumor: development of risk prediction models and therapeutic implications

in Cancer Molecular Targets and Therapeutics

Qiang Zeng
Junfeng Tao
Lilu Qin
Yong Zeng
Zhong Liu
Mingxian Xu
Linshan Zeng

Frontiers in Oncology

doi 10.3389/fonc.2024.1501718

1,361 views

Systematic Review

Published on 25 Nov 2024

Potential urinary volatile organic compounds as screening markers in cancer – a review

in Cancer Molecular Targets and Therapeutics

Alexandre Goertzen
Biniam Kidane
Naseer Ahmed
Michel Aliani

Frontiers in Oncology

doi 10.3389/fonc.2024.1448760

3,084 views
3 citations

Original Research

Published on 22 Nov 2024

Identification of key genes associated with endometriosis and endometrial cancer by bioinformatics analysis

in Cancer Molecular Targets and Therapeutics

Ruyue Ma
Yu Zheng
Jianing Wang
Hong Xu
Ruirui Zhang
Zhijia Xie
Lei Zhang
Ruiheng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1387860

2,680 views
2 citations

Original Research

Published on 22 Nov 2024

SLNP-based CDK4- targeted nanotherapy against glioblastoma

in Cancer Molecular Targets and Therapeutics

Uzma Ghani
Fareeha Khalid Ghori
Muhammad Usman Qamar
Hina Khan
Basit Azad
Sabahat Habib
Saira Justin
Ishaq N. Khan
Tawaf Ali Shah
Gamal A. Shazly

Frontiers in Oncology

doi 10.3389/fonc.2024.1455816

1,746 views
1 citation

Review

Published on 21 Nov 2024

The effectiveness of acupuncture in cancer pain treatment

in Cancer Molecular Targets and Therapeutics

Kamila Krukowska
Sylwia Krzyśkowska
Eliza Kuchta
Anna Rudzińska
Katarzyna Szklener
Sławomir Mańdziuk

Frontiers in Oncology

doi 10.3389/fonc.2024.1450105

2,954 views

Systematic Review

Published on 20 Nov 2024

Clinicopathological significance and prognostic values of claudin18.2 expression in solid tumors: a systematic review and meta-analysis

in Cancer Molecular Targets and Therapeutics

Gyerim Park
Se Jun Park
Younghoon Kim

Frontiers in Oncology

doi 10.3389/fonc.2024.1453906

2,060 views
1 citation